PDF
ePub
Citation
Print
Abstract
The prevalence of diabetes mellitus (DM) has increased, with about 30% of patients over the age of 65 suffering from diabetes. Because DM requires intensive treatment, the rate of insulin use has increased in elderly diabetes patients. The elderly can suffer from physical, psychological, and socioeconomic problems, making it difficult to administer insulin injections. When educating elderly diabetic patients, it is necessary to reduce psychological insulin resistance and to educate them about the physical diseases related to aging and complications. Also, the patients should be provided appropriate educational materials and informed of available resources. It is important for elderly diabetes patients to receive continuous repetition and encouragement for proper insulin administration.
References
1. Korean Diabetes Association. Diabetes fact sheet in Korea 2016. Seoul: Korean Diabetes Association;2016.
2. Ko SH, Hur KY, Rhee SY, Kim NH, Moon MK, Park SO, Lee BW, Kim HJ, Choi KM, Kim JH. Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean diabetes association. Diabetes Metab J. 2017; 41:337–348.
3. Lee BW, Kim JH, Ko SH, Hur KY, Kim NH, Rhee SY, Kim HJ, Moon MK, Park SO, Choi KM. Committee of Clinical Practice Guideline of Korean Diabetes Association. Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017. Diabetes Metab J. 2017; 41:367–373.
4. Lee JR. Evidence for questions by diabetes educators when teaching insulin injection in clinical practice. J Korean Diabetes. 2017; 18:109–116.
5. Lee J. New guidelines for elderly diabetic patients. J Korean Diabetes. 2015; 16:89–100.
6. Shin JW, Park YK, Suh SR, Kim JE. Factors influencing quality of life in elderly diabetic patients of Korea: analysis from the Korea National Health and Nutrition Examination Survey in 2008. J Korean Gerontol Soc. 2011; 31:479–487.
7. Davis SN, Renda SM. Psychological insulin resistance: overcoming barriers to starting insulin therapy. Diabetes Educ. 2006; 32 Suppl 4. 146S–152S.
8. Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008; 34:382–385.
9. Bridgeman B, Lewis S, Heit G, Nagle M. Relation between cognitive and motor-oriented systems of visual position perception. J Exp Psychol Hum Percept Perform. 1979; 5:692–700.
10. Yun HS, Kim MA, Kim MH, Suh SR, Kim H. Evaluation of visual-motor integration in elderly patient with diabetes mellitus. J Korean Gerontol Soc. 2011; 31:642–652.
11. Hirsch L, Byron K, Gibney M. Intramuscular risk at insulin injection sites: measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes Technol Ther. 2014; 16:867–873.
12. Birkebaek NH, Solvig J, Hansen B, Jorgensen C, Smedegaard J, Christiansen JS. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care. 2008; 31:e65.
13. Riddle MC. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin North Am. 2005; 34:77–98.
14. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009; 4:e4144.
15. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5:64–74.
XML Download